Pasquale Pignatelli

Pubblicazioni

Titolo Pubblicato in Anno
Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention THE AMERICAN JOURNAL OF CARDIOLOGY 2020
Antiphospholipid antibodies and lower extremity peripheral artery disease: A systematic review and meta-analysis SEMINARS IN ARTHRITIS AND RHEUMATISM 2020
Is Albumin Predictor of Mortality in COVID-19? ANTIOXIDANTS & REDOX SIGNALING 2020
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register BMJ OPEN 2020
Letter by violi et al regarding article, "rivaroxaban reduces arterial thrombosis by inhibition of fxa-driven platelet activation via protease activated receptor-1" CIRCULATION RESEARCH 2020
Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin BIOCHEMICAL PHARMACOLOGY 2019
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study MAYO CLINIC PROCEEDINGS 2019
Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2019
Acute Effects of Heat-Not-Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking ( SUR - VAPES ) 2 Randomized Trial JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2019
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review JOURNAL OF ALZHEIMER'S DISEASE 2019
Tailored practical management of patients with atrial fibrillation. a risk factor-based approach FRONTIERS IN CARDIOVASCULAR MEDICINE 2019
Update and unmet needs on the use of nonvitamin k Oral anticoagulants for stroke prevention in patients with atrial fibrillation CURRENT PROBLEMS IN CARDIOLOGY 2019
Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. a systematic review and bayesian meta-regression analysis AUTOIMMUNITY REVIEWS 2019
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study THE AMERICAN JOURNAL OF MEDICINE 2019
Silybin and metabolic disorders INTERNAL AND EMERGENCY MEDICINE 2019
Antiplatelet treatment in acute coronary syndrome patients. real-world data from the START-Antiplatelet italian registry PLOS ONE 2019
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation. a post-hoc analysis from the ATHERO-AF cohort ATHEROSCLEROSIS 2019
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study FRONTIERS IN ENDOCRINOLOGY 2019
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation MAYO CLINIC PROCEEDINGS 2019
Does the Coexistence of Chronic Obstructive Pulmonary Disease and Atrial Fibrillation Affect Nox2 Activity and Urinary Isoprostanes Excretion? ANTIOXIDANTS & REDOX SIGNALING 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma